Management of bleeding in patients taking FXa and FIIa inhibitors
Sudden onset bilateral deafness as a presentation of chronic myeloid leukaemia
Triphenotypic multiple myeloma expressing kappa or lambda light chain or both
Molecular determinants of platelet delta storage pool deficiencies: an update
How I manage patients with atypical microcytic anaemia
Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
Guideline on the management of bleeding in patients on antithrombotic agents
Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice
The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under-expression of TP53 and other genes on chromosome 17p
Abnormal serum free light chain ratio predicts poor overall survival in mantle cell lymphoma
Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population
Treatment of children with acute myeloid leukaemia who relapsed after allogeneic haematopoietic stem cell transplantation
Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector function
HbA2 levels in normal adults are influenced by two distinct genetic mechanisms
BCL7A protein expression in normal and malignant lymphoid tissues
High incidence of Fanconi anaemia in patients with a morphological picture consistent with refractory cytopenia of childhood
Schedule dependent cytotoxicity of bortezomib and melphalan in multiple myeloma
Occupancy of whole blood cells by a single PIGA -mutant clone with HMGA2 amplification in a paroxysmal nocturnal haemoglobinuria patient having blood cells with NKG2D ligands
Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation